Literature DB >> 36099144

Medicinal Plants Used for Abdominal Discomfort - Information from Cancer Patients and Medical Students.

Soeren Klaus Buentzel1, Jutta Huebner1, Judith Buentzel2, Oliver Micke3.   

Abstract

BACKGROUND/AIM: Abdominal discomfort during tumour therapy often leads to the use of phytotherapeutics from the field of folk medicine. What knowledge base do patients and young physicians have when they come across this phenomenon together? PATIENTS AND METHODS: We conducted an online survey of 157 medical students and, in consultation, 125 patients according to a standardised algorithm about their knowledge and use of a list of given medicinal plants for the above-mentioned symptomatology. We previously created the list of traditional German medicinal plants taking into account the symptoms of bloating, fullness, diarrhoea, constipation, and nausea. Both data pools are presented descriptively, compared using principal component analysis, and student knowledge was subjected to network analysis.
RESULTS: As a median, patients know 9 medicinal plants and use 4 species. Students know 10 medicinal plants and use 5 species. The rate of non-users is 13.6% among patients and 11.4% among students. The plants used by both groups are ginger and mint, whereas patients also use camomile and fennel. The nearly coincident knowledge profile speaks of a common knowledge base - folk medicine. Network analysis illustrated that students stored their knowledge in symptom clusters.
CONCLUSION: Patients with cancer and students are familiar with a similar canon of medicinal plants for the treatment of abdominal discomfort. Their common source is folk medicine. Targeted instructions on evidence-based phytotherapy are needed to improve students' existing symptom-cluster-related knowledge.
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Phytotherapy; abdominal discomfort; cancer patients; medical students; self-medication

Mesh:

Substances:

Year:  2022        PMID: 36099144      PMCID: PMC9463914          DOI: 10.21873/invivo.12976

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.406


  39 in total

Review 1.  Acupuncture for treatment of irritable bowel syndrome.

Authors:  Eric Manheimer; Ke Cheng; L Susan Wieland; Li Shih Min; Xueyong Shen; Brian M Berman; Lixing Lao
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 2.  Psychological aspects of nutrition and cancer.

Authors:  G V Padilla
Journal:  Surg Clin North Am       Date:  1986-12       Impact factor: 2.741

Review 3.  Adverse events of moxibustion: a systematic review.

Authors:  Ji-Eun Park; Song-Shil Lee; Myeong Soo Lee; Sun-Mi Choi; Edzard Ernst
Journal:  Complement Ther Med       Date:  2010-08-19       Impact factor: 2.446

4.  Information needs and usage of complementary and alternative medicine in members of a German self-help group for gastrointestinal stroma tumours, sarcoma, and renal cancer.

Authors:  Fabienne Bauer; Thorsten Schmidt; Hannah Eisfeld; Clara Dubois; Karin Kastrati; Andreas Hochhaus; Jutta Huebner
Journal:  Complement Ther Med       Date:  2018-09-11       Impact factor: 2.446

5.  The Role of Acupuncture on the Gut-Brain-Microbiota Axis in Irritable Bowel Syndrome.

Authors:  Kiangyada Yaklai; Sintip Pattanakuhar; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Am J Chin Med       Date:  2021-02-20       Impact factor: 4.667

6.  Meta-analysis of traditional Chinese medicine in treating functional dyspepsia of liver-stomach disharmony syndrome.

Authors:  Chuijie Wang; Mingjin Zhu; Wei Xia; Wei Jiang; Yan Li
Journal:  J Tradit Chin Med       Date:  2012-12       Impact factor: 0.848

7.  Tormentil for active ulcerative colitis: an open-label, dose-escalating study.

Authors:  Roman Huber; Amelie V Ditfurth; Frank Amann; Corina Güthlin; Matthias Rostock; Rainer Trittler; Klaus Kümmerer; Irmgard Merfort
Journal:  J Clin Gastroenterol       Date:  2007-10       Impact factor: 3.062

8.  Lay Etiology, Self-Efficacy and Patient Activation Among Cancer Patients.

Authors:  Saskia Welter; Christian Keinki; Emadaldin Ahmadi; Jutta Huebner
Journal:  Cancer Invest       Date:  2021-02-02       Impact factor: 2.176

9.  Effect of Samryungbaekchul-san Combined with Otilonium Bromide on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial.

Authors:  Jin-Hyun Lee; Joong Il Kim; Myong Ki Baeg; Yun-Young Sunwoo; Kwangsun Do; Jung-Han Lee; Hye-Jung Kim; Ja Sung Choi; Jayoung Kim; Chang-Seob Seo; Hyeun-Kyoo Shin; Hyekyung Ha; Tae-Yong Park
Journal:  J Clin Med       Date:  2019-09-27       Impact factor: 4.241

10.  Predictive values for different cancers and inflammatory bowel disease of 6 common abdominal symptoms among more than 1.9 million primary care patients in the UK: A cohort study.

Authors:  Annie Herbert; Meena Rafiq; Tra My Pham; Cristina Renzi; Gary A Abel; Sarah Price; Willie Hamilton; Irene Petersen; Georgios Lyratzopoulos
Journal:  PLoS Med       Date:  2021-08-02       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.